Mebendazole
(OPXLLQIJSORQAM-UHFFFAOYSA-N)
Structure
- SMILES
- COC(=O)Nc1nc2c([nH]1)cc(cc2)C(=O)c1ccccc1
- Type(s)
- Approved; Vet_approved
- ATC code(s)
- P02CA01; P02CA51
- Molecular Formula:
- C16H13N3O3
- Molecular Weight:
- 295.293
- Log P:
- 3.0452
- Hydrogen Bond Acceptor:
- 5
- Hydrogen Bond Donor:
- 2
- TPSA:
- 84.08
- CAS Number(s):
- 31431-39-7
Synonym(s)
1.
Mebendazole
2.
Anti-Worm
3.
Bantenol
4.
Banworm
5.
Boots Threadworm Treatment
6.
Lomper
7.
Madicure
8.
Mebendan
9.
Mebenvet
10.
Pripsen Mebendazole
11.
R17635
12.
Sqworm
13.
Sufil
14.
Surfont
15.
Telmin
16.
Vermicol
17.
Vermidil
18.
Vermox
19.
Wormkuur
20.
Anti Worm
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 35 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Abdominal Pain | FAERS: 24 Canada Vigilance: 1 | 7330947 | CTD SIDER Canada Vigilance US FAERS |
| 3 | Nausea | FAERS: 21 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | Vomiting | FAERS: 21 Canada Vigilance: 2 | 7330947 | CTD Canada Vigilance US FAERS |
| 5 | Dizziness | FAERS: 20 Canada Vigilance: 2 | 7330947 | CTD Canada Vigilance US FAERS |
| 6 | Drug exposure during pregnancy | FAERS: 19 | OFFSIDES US FAERS | |
| 7 | Headache | FAERS: 15 Canada Vigilance: 3 | 7330947 | CTD Canada Vigilance US FAERS |
| 8 | Urticaria | FAERS: 13 | SIDER US FAERS | |
| 9 | Pruritus | FAERS: 11 | US FAERS | |
| 10 | Drug effect incomplete | FAERS: 10 | US FAERS | |
| 11 | Asthenia | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 12 | Hypersensitivity | FAERS: 9 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 13 | General physical health deterioration | FAERS: 8 | US FAERS | |
| 14 | Malaise | FAERS: 7 | US FAERS | |
| 15 | Agranulocytosis | FAERS: 6 | SIDER US FAERS | |
| 16 | Fatigue | FAERS: 6 | US FAERS | |
| 17 | Pain | FAERS: 6 | US FAERS | |
| 18 | Angioedema | FAERS: 5 | OFFSIDES SIDER US FAERS | |
| 19 | Conjunctivitis | FAERS: 5 | US FAERS | |
| 20 | Myalgia | FAERS: 5 | US FAERS | |
| 21 | Abdominal tenderness | FAERS: 4 | OFFSIDES US FAERS | |
| 22 | Adverse event | FAERS: 4 | US FAERS | |
| 23 | Alopecia | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 24 | Chills | FAERS: 4 | US FAERS | |
| 25 | Encephalitis | FAERS: 4 | US FAERS | |
| 26 | Feeling abnormal | FAERS: 4 | US FAERS | |
| 27 | Incorrect drug administration duration | FAERS: 4 | US FAERS | |
| 28 | Neutropenia | FAERS: 4 | SIDER US FAERS | |
| 29 | Overdose | FAERS: 4 | US FAERS | |
| 30 | Product prescribing issue | FAERS: 4 | US FAERS | |
| 31 | Product use issue | FAERS: 4 | US FAERS | |
| 32 | Toxicity to various agents | FAERS: 4 | US FAERS | |
| 33 | Accidental exposure to product by child | FAERS: 3 | US FAERS | |
| 34 | Asthma | FAERS: 3 | US FAERS | |
| 35 | Blood immunoglobulin E increased | FAERS: 3 | US FAERS | |
| 36 | Burning sensation | FAERS: 3 | US FAERS | |
| 37 | Cerebrovascular accident | FAERS: 3 | US FAERS | |
| 38 | Disease complication | FAERS: 3 | OFFSIDES US FAERS | |
| 39 | Disorientation | FAERS: 3 | US FAERS | |
| 40 | Drug ineffective for unapproved indication | FAERS: 3 | US FAERS | |
| 41 | Epilepsy | FAERS: 3 | US FAERS | |
| 42 | Henoch-Schonlein purpura nephritis | FAERS: 3 | US FAERS | |
| 43 | Incorrect dose administered | FAERS: 3 | US FAERS | |
| 44 | Oral mucosal eruption | FAERS: 3 | US FAERS | |
| 45 | Oropharyngeal pain | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 46 | Product use in unapproved indication | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 47 | Respiratory Failure | FAERS: 3 | US FAERS | |
| 48 | Somnolence | FAERS: 3 | US FAERS | |
| 49 | Therapeutic response unexpected | FAERS: 3 | US FAERS | |
| 50 | Thrombocytopenia | FAERS: 3 | US FAERS | |
| 51 | Tremor | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 52 | Abdominal discomfort | FAERS: 2 | US FAERS | |
| 53 | Accidental overdose | FAERS: 2 | US FAERS | |
| 54 | Agitation | FAERS: 2 | US FAERS | |
| 55 | Anaphylactic shock | FAERS: 2 | US FAERS | |
| 56 | Ataxia | FAERS: 2 | US FAERS | |
| 57 | Bedridden | FAERS: 2 | US FAERS | |
| 58 | Biliary Fistula | FAERS: 2 | OFFSIDES US FAERS | |
| 59 | Blood immunoglobulin G increased | FAERS: 2 | OFFSIDES US FAERS | |
| 60 | Bronchial Fistula | FAERS: 2 | OFFSIDES US FAERS | |
| 61 | Cytolytic hepatitis | FAERS: 2 | US FAERS | |
| 62 | Drug level increased | FAERS: 2 | US FAERS | |
| 63 | Drug toxicity | FAERS: 2 | US FAERS | |
| 64 | Dysentery | FAERS: 2 | US FAERS | |
| 65 | Enterobiasis | FAERS: 2 | OFFSIDES US FAERS | |
| 66 | Erythema | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 67 | Flatulence | FAERS: 2 | US FAERS | |
| 68 | Haematotoxicity | FAERS: 2 | OFFSIDES US FAERS | |
| 69 | Hypospadias | FAERS: 2 | US FAERS | |
| 70 | Incorrect product formulation administered | FAERS: 2 | US FAERS | |
| 71 | Intentional product misuse | FAERS: 2 | US FAERS | |
| 72 | Medication Error | FAERS: 2 | US FAERS | |
| 73 | Myocardial necrosis marker increased | FAERS: 2 | US FAERS | |
| 74 | Oral mucosal exfoliation | FAERS: 2 | OFFSIDES US FAERS | |
| 75 | Pneumonia | FAERS: 2 | US FAERS | |
| 76 | Prescribed overdose | FAERS: 2 | US FAERS | |
| 77 | Product counterfeit | FAERS: 2 | US FAERS | |
| 78 | Somatoform Disorder | FAERS: 2 | US FAERS | |
| 79 | Suspected counterfeit product | FAERS: 2 | US FAERS | |
| 80 | Swelling | FAERS: 2 | US FAERS | |
| 81 | Syncope | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 82 | Talipes | FAERS: 2 | US FAERS | |
| 83 | Throat irritation | FAERS: 2 | US FAERS | |
| 84 | Trisomy 21 | FAERS: 2 | OFFSIDES US FAERS | |
| 85 | Visual Impairment | FAERS: 2 | US FAERS | |
| 86 | jaundice | FAERS: 2 | US FAERS | |
| 87 | pseudomembranous colitis | FAERS: 2 | US FAERS | |
| 88 | treatment failure | FAERS: 2 | US FAERS | |
| 89 | Abasia | FAERS: 1 | US FAERS | |
| 90 | Abscess | FAERS: 1 | US FAERS | |
| 91 | Acarodermatitis | FAERS: 1 | US FAERS | |
| 92 | Alanine Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 93 | Amnesia | FAERS: 1 | US FAERS | |
| 94 | Anaphylactoid Reaction | FAERS: 1 | US FAERS | |
| 95 | Antibody test positive | FAERS: 1 | US FAERS | |
| 96 | Aphagia | FAERS: 1 | US FAERS | |
| 97 | Aphasia | FAERS: 1 | US FAERS | |
| 98 | Arthropathy | FAERS: 1 | OFFSIDES US FAERS | |
| 99 | Ascites | FAERS: 1 | US FAERS | |
| 100 | Blood alkaline phosphatase increased | FAERS: 1 | US FAERS | |
| 101 | Cachexia | FAERS: 1 | US FAERS | |
| 102 | Chest Pain | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 103 | Cholangitis | FAERS: 1 | US FAERS | |
| 104 | Chronic Fatigue Syndrome | FAERS: 1 | US FAERS | |
| 105 | Cleft Palate | FAERS: 1 | US FAERS | |
| 106 | Complications of maternal exposure to therapeutic drugs | FAERS: 1 | OFFSIDES US FAERS | |
| 107 | Congenital Hydrocephalus | FAERS: 1 | US FAERS | |
| 108 | Congenital heart valve disorder | FAERS: 1 | US FAERS | |
| 109 | Counterfeit drug administered | FAERS: 1 | US FAERS | |
| 110 | Dehydration | FAERS: 1 | US FAERS | |
| 111 | Diabetes mellitus inadequate control | FAERS: 1 | US FAERS | |
| 112 | Diet refusal | FAERS: 1 | US FAERS | |
| 113 | Disease Progression | FAERS: 1 | US FAERS | |
| 114 | Disease recurrence | FAERS: 1 | US FAERS | |
| 115 | Drug Dependence | FAERS: 1 | US FAERS | |
| 116 | Drug abuse | FAERS: 1 | US FAERS | |
| 117 | Drug exposure via breast milk | FAERS: 1 | US FAERS | |
| 118 | Drug prescribing error | FAERS: 1 | US FAERS | |
| 119 | Dyspepsia | FAERS: 1 | US FAERS | |
| 120 | Eclampsia | FAERS: 1 | US FAERS | |
| 121 | Emergency Care | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 122 | Epistaxis | FAERS: 1 | US FAERS | |
| 123 | Erythema Infectiosum | FAERS: 1 | US FAERS | |
| 124 | Exfoliative rash | FAERS: 1 | US FAERS | |
| 125 | Failure of child resistant mechanism for pharmaceutical product | FAERS: 1 | US FAERS | |
| 126 | Flushing | FAERS: 1 | US FAERS | |
| 127 | Forceps delivery | FAERS: 1 | US FAERS | |
| 128 | Gamma-Glutamyltransferase Increased | FAERS: 1 | US FAERS | |
| 129 | Gastroenteritis | FAERS: 1 | US FAERS | |
| 130 | Glomerulonephritis | FAERS: 1 | 7173081 | CTD US FAERS |
| 131 | Gluten sensitivity | FAERS: 1 | US FAERS | |
| 132 | Granulomatous liver disease | FAERS: 1 | US FAERS | |
| 133 | Hip Dysplasia | FAERS: 1 | US FAERS | |
| 134 | Hypodontia | FAERS: 1 | US FAERS | |
| 135 | Inappropriate schedule of drug administration | FAERS: 1 | US FAERS | |
| 136 | Infection | FAERS: 1 | US FAERS | |
| 137 | Irritable Bowel Syndrome | FAERS: 1 | US FAERS | |
| 138 | Lactose Intolerance | FAERS: 1 | US FAERS | |
| 139 | Laryngitis | FAERS: 1 | US FAERS | |
| 140 | Lethargy | FAERS: 1 | US FAERS | |
| 141 | Leukoencephalomyelitis | FAERS: 1 | US FAERS | |
| 142 | Lip swelling | FAERS: 1 | US FAERS | |
| 143 | Meningitis | FAERS: 1 | US FAERS | |
| 144 | Multiple allergies | FAERS: 1 | US FAERS | |
| 145 | Neck Pain | FAERS: 1 | US FAERS | |
| 146 | Nephrotic Syndrome | FAERS: 1 | US FAERS | |
| 147 | Nervousness | FAERS: 1 | US FAERS | |
| 148 | Neutropenic sepsis | FAERS: 1 | US FAERS | |
| 149 | Nonspecific reaction | FAERS: 1 | US FAERS | |
| 150 | Paraplegia | FAERS: 1 | US FAERS | |
| 151 | Peripheral swelling | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 152 | Petechiae | FAERS: 1 | US FAERS | |
| 153 | Poisoning | FAERS: 1 | US FAERS | |
| 154 | Pre-Eclampsia | FAERS: 1 | US FAERS | |
| 155 | Pregnancy | FAERS: 1 | US FAERS | |
| 156 | Prescription drug used without a prescription | FAERS: 1 | US FAERS | |
| 157 | Product packaging issue | FAERS: 1 | US FAERS | |
| 158 | Product quality issue | FAERS: 1 | US FAERS | |
| 159 | Product substitution issue | FAERS: 1 | US FAERS | |
| 160 | Product taste abnormal | FAERS: 1 | US FAERS | |
| 161 | Pulmonary echinococciasis | FAERS: 1 | US FAERS | |
| 162 | Rash erythematous | FAERS: 1 | US FAERS | |
| 163 | Reaction to drug excipients | FAERS: 1 | US FAERS | |
| 164 | Restlessness | FAERS: 1 | US FAERS | |
| 165 | Retching | FAERS: 1 | US FAERS | |
| 166 | Sinusitis | FAERS: 1 | US FAERS | |
| 167 | Skin toxicity | FAERS: 1 | US FAERS | |
| 168 | Stevens-Johnson Syndrome | FAERS: 1 | US FAERS | |
| 169 | Strabismus | FAERS: 1 | US FAERS | |
| 170 | Sudden death | FAERS: 1 | US FAERS | |
| 171 | Vertigo | FAERS: 1 | US FAERS | |
| 172 | Vitiligo | FAERS: 1 | US FAERS | |
| 173 | Weight decreased | FAERS: 1 | US FAERS | |
| 174 | Wheezing | FAERS: 1 | US FAERS | |
| 175 | Wrong drug administered | FAERS: 1 | US FAERS | |
| 176 | Zygomycosis | FAERS: 1 | US FAERS | |
| 177 | Accidental exposure | OFFSIDES | ||
| 178 | Activities of daily living impaired | OFFSIDES | ||
| 179 | Alopecia totalis | OFFSIDES | ||
| 180 | Amphetamines | OFFSIDES | ||
| 181 | Anemia | 14747671 | CTD | |
| 182 | Anger | OFFSIDES | ||
| 183 | Anhedonia | OFFSIDES | ||
| 184 | Anxiety | Canada Vigilance: 1 | Canada Vigilance | |
| 185 | Ascariasis | 18430913 | CTD | |
| 186 | Atrial Flutter | OFFSIDES | ||
| 187 | Back Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 188 | Blood immunoglobulin E | OFFSIDES | ||
| 189 | Bone marrow depression | OFFSIDES | ||
| 190 | Breakthrough Pain | OFFSIDES | ||
| 191 | Chemical and Drug Induced Liver Injury | 3692093 20848085 23152190 | CTD | |
| 192 | Child Nutrition Disorders | 14747671 | CTD | |
| 193 | Chromaturia | OFFSIDES | ||
| 194 | Depression suicidal | OFFSIDES | ||
| 195 | Dermatitis | SIDER | ||
| 196 | Diarrhea | 7330947 | CTD | |
| 197 | Drug addict | OFFSIDES | ||
| 198 | Echinococcosis, Hepatic | 3692093 4083626 | CTD | |
| 199 | Echinococcosis | 7173081 7330947 9838237 | CTD | |
| 200 | Emotional disorder | OFFSIDES | ||
| 201 | Gastrointestinal Pain | SIDER | ||
| 202 | Gastrointestinal inflammation | OFFSIDES | ||
| 203 | Helminthiasis | 21254932 | CTD | |
| 204 | Hepatitis | OFFSIDES SIDER | ||
| 205 | Hymenolepiasis | 7330947 | CTD | |
| 206 | Hyperreflexia | OFFSIDES | ||
| 207 | Infant Nutrition Disorders | 14747671 | CTD | |
| 208 | Joint injury | OFFSIDES | ||
| 209 | Larva Migrans | 16205517 | CTD | |
| 210 | Left Ventricular Hypertrophy | OFFSIDES | ||
| 211 | Liver diseases | 21254932 | CTD | |
| 212 | Lysosomal Storage Diseases | 28551711 | CTD | |
| 213 | Menorrhagia | SIDER | ||
| 214 | Multiple drug overdose intentional | OFFSIDES | ||
| 215 | Musculoskeletal stiffness | Canada Vigilance: 1 | Canada Vigilance | |
| 216 | Mycoplasma serology | OFFSIDES | ||
| 217 | Nematode infections | 7330947 | CTD | |
| 218 | Pancreatitis | OFFSIDES | ||
| 219 | Prolonged menses | SIDER | ||
| 220 | Pulmonary Valve Stenosis | OFFSIDES | ||
| 221 | Secernentea Infections | 10727200 | CTD | |
| 222 | Sparganosis | 7330947 | CTD | |
| 223 | Status Epilepticus | 10727200 | CTD | |
| 224 | Vanishing bile duct syndrome | OFFSIDES | ||
| 225 | Ventricular hypoplasia | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.